A practical reference on IGF-1: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-30 and is reviewed periodically as new material appears.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
==== Extensive percutaneous aponeurotomy and lipografting ==== A technique introduced in 2011 is extensive percutaneous aponeurotomy with lipografting. This procedure also uses a needle to cut the cords. The difference with the percutaneous needle fasciotomy is that the cord is cut at many places. The cord is also separated from the skin to make place for the lipograft that is taken from the abdomen or ipsilateral flank. This technique shortens the recovery time. The fat graft results in supple skin. Before the aponeurotomy, a liposuction is done to the abdomen and ipsilateral flank to collect the lipograft. The treatment can be performed under regional or general anesthesia. The digits are placed under maximal extension tension using a firm lead hand retractor. The surgeon makes multiple palmar puncture wounds with small nicks. The tension on the cords is crucial, because tight constricting bands are most susceptible to be cut and torn by the small nicks, whereas the relatively loose neurovascular structures are spared. After the cord is completely cut and separated from the skin the lipograft is injected under the skin. A total of about 5 to 10 ml is injected per ray. After the treatment the person wears an extension splint for 5 to 7 days. Thereafter the person returns to normal activities and is advised to use a night splint for up to 20 weeks.
Cone snails are prized for their brightly colored and patterned shells, which may tempt people to pick them up. This is risky, as the snail often fires its harpoon in self defense when disturbed. The harpoons of some of the larger species of cone snail can penetrate gloves or wetsuits. The sting of many of the smallest cone species may be no worse than a bee or hornet sting, but the sting of a few of the larger tropical fish-eating species, such as Conus geographus (geography cone), Conus tulipa and Conus striatus, can be fatal. Other dangerous species are Conus pennaceus, Conus textile, Conus aulicus, Conus magus and Conus marmoreus. According to Goldfrank's Toxicologic Emergencies, about 27 human deaths can be confidently attributed to cone snail envenomation, though the actual number is almost certainly much higher; some three dozen people are estimated to have died from geography cone envenomation alone. Most of the cone snails that hunt worms are not a risk to humans, with the exception of larger species. One of the fish-eating species, the geography cone, is also known colloquially as the "cigarette snail", a gallows humor exaggeration implying that, when stung by this creature, the victim will have only enough time to smoke a cigarette before dying. Symptoms of a more serious cone snail sting include severe, localized pain, swelling, numbness and tingling, and vomiting. Symptoms can start immediately or can be delayed for days. Severe cases involve muscle paralysis, changes in vision and respiratory failure that can lead to death.
=== Deka Base === The Deka Base (デカベース, Deka Bēsu) is the primary headquarters and base of operations of the S.P.D. Earth unit. It is equipped with Base Beams (ベースビーム, Bēsu Bīmu) and houses the Deka Machines. Additionally, the Deka Base can transform into either the Deka Base Crawler (デカベースクローラー, Deka Bēsu Kurōrā), which is equipped with the Crawler Beam (クローラービーム, Kurōrā Bīmu) cannons, or the humanoid Deka Base Robo (デカベースロボ, Deka Bēsu Robo), which is equipped with Finger Missiles (フィンガーミサイル, Fingā Misairu) and Knee Brace Beams (ニーブレスビーム, Nī Buresu Bīmu). Deka Base Robo's finisher is the Volcanic Buster (ヴォルカニック・バスター, Vorukanikku Basutā). As of the direct-to-video anniversary special Tokusou Sentai Dekaranger: 10 Years After, the Deka Base has been rebuilt and renamed the Neo Deka Base (ネオデカベース, Neo Deka Bēsu). As of the direct-to-video anniversary special Tokusou Sentai Dekaranger 20th: Fireball Booster, the Neo Deka Base has been rebuilt and renamed the Shin Neo Deka Base (シン・ネオデカベース, Shin Neo Deka Bēsu).
=== Trade war === Political scientist Hilmar Mjelde called Trump's actions a "political own goal of historic proportions", and said he believes Trump has underestimated European steadfastness. Annie Genevard said the EU has strong leverage and can retaliate in a trade war with the US, and that it could be "deadly for the United States", emphasising that Europeans will not let the US do as it pleases.
== Military career == After graduating from the Military Academy, al-Burhan worked in Khartoum, as part of the Sudanese army, and participated in the fighting fronts in the Darfur war and in the Second Sudanese Civil War in South Sudan and other regions. He was regional commander in Darfur. He later traveled to Egypt and then to Jordan to receive training courses in his military field until in 2018 he was appointed commander of the ground forces of the army. Al-Burhan held several positions throughout his career as he began as a soldier with the Border Guard Forces and later became commander of this force before becoming Deputy Chief of Staff of the Ground Forces Operations and then Chief of Staff of the Sudanese Army in February 2018 before he served as Inspector General of the Army for a period of time. By 26 February 2019, during the massive protests that swept the country and demanded the fall of Omar al-Bashir's regime, al-Burhan was elevated to the rank of lieutenant general.
Sources: en.wikipedia.org
Treatment of cancer cells with peptide δ-361 finally resulted to microtubule destabilization and cell death. Fine-mapping of the DDX3X interaction domains on CK1δ, the CK1δ- peptides δ-1, and δ-41 were identified to be able to block the interactions of CK1δ with the X-linked DEAD box RNA helicase DDX3X as well as the kinase activity of CK1δ. In addition, these two identified peptides could inhibit the stimulation of CK1 kinase activity in established cell lines. Since DDX3X mutations being present in medulloblastoma patients increase the activity of CK1 in living cells, and subsequently activate CK1-regulated pathways like Wnt/β-catenin and hedgehog signaling, the identified interaction-blocking peptides could be useful in personalized therapy concepts for the treatment of Wnt/β-catenin- or Hedgehog-driven cancers. In 2018, the interaction between Axin1, a scaffold protein exhibiting important roles in Wnt signaling, and CK1δ/ε were fine-mapped using a peptide library. The identified Axin1 derived peptides were able to block the interaction with CK1δ/ε. Since Axin1 and Dvl also compete for CK1δ/ε-mediated site-specific phosphorylation it can be stated that Axin 1 plays an important role of in balancing CK1δ/ε mediated phosphorylation of Dvl as well as for the activation of canonical Wnt signaling.
== Political organization == Lad served as General Secretary of the Karnataka Pradesh Congress Committee (KPCC) and was given responsibility for Raichur district organization during his earlier period in Congress politics. In January 2023, the Congress appointed Lad as a co-chairman in the party's Karnataka Assembly election campaign committee, with responsibility for the Belagavi division. He also participated in Congress's Bharat Jodo Yatra activities in Karnataka in 2022. Lad started his political career as a counsellor from Sandur taluk. He had very little success in Pattana panchayat elections, where he lost marginally in his first election. He went on to win both seats he contested in the following election, contributing to his party gaining the majority during that period. Lad contested the MLA election against a strong contender from the Congress Party. He represented the Janata Dal (Secular) party and was the youngest MLA (aged 29), along with the first person from his party to win Sandur constituency; the election was won with a record margin. Lad was part of the government formation under H. D. Kumaraswamy, ex-chief minister of the Karnataka state. In the 2008 Karnataka Assembly elections, he won the Kalaghatgi constituency in the Dharwad district. He currently is an active member and represents Indian National Congress. In the 2013 Karnataka state assembly election, Santosh Lad won with a margin of over 45,000 votes, to win consecutively for the second time from Kalaghatgi and third time overall. Congress secured an absolute majority to form the government.
In May 1878 Eddy brought a case against Daniel Spofford, in Salem, Massachusetts, for practicing mesmerism. It came to be known as the second Salem witchcraft trial. The case was filed in the name of one of Spofford's patients, Lucretia Brown, who said that he had bewitched her, though Eddy appeared in court on Brown's behalf. In preparation for the hearing, Eddy organized a 24-hour watch at 8 Broad Street, during which she asked 12 students to think about Spofford for two hours each and block malicious mesmerism from him. She arrived at the court with 20 supporters, including Amos Bronson Alcott (a "cloud of witnesses," according to the Boston Globe), but Judge Horace Gray dismissed the case. The attempt to have Spofford tried was not the end of the dispute. In October 1878 Eddy's husband and another student, Edward Arens, were charged with conspiring to murder Spofford. A barman said they had offered him $500 to do it; after a complex series of claims and counter-claims, the charges were dropped when a witness retracted his statement. Eddy attributed the allegation to a plot by former students to undermine sales of the second edition of Science and Health, just published. Her lawyer had to apply for an attachment order against her house to collect his fee.
=== Crystal Anderson-Conner === Crystal Anderson-Conner is played by Natalie West. Crystal is a close friend of Roseanne, having gone to high school with her and Jackie and later working together with them at Wellman Plastics. A mild-mannered, good-hearted woman, Crystal's kindness is often taken advantage of, even by Roseanne at times. Though Crystal is not oblivious to others using her, she seldom asserts herself, fearing she might lose others' favor or be perceived as unladylike. Crystal's most poignant hallmark is her dating troubles. At the beginning of the series, she has been married three times. Both her marriages to Rusty and Travis, were fairly short and ended in divorce. (However, in season 1, episode 5, it is mentioned that she was widowed at 18.) Her third husband Sonny, the father of her son Lonnie, was killed in a bridge construction accident. After, Crystal endures years of bad relationships before gradually kindling a romance with Dan's father Ed, much to Roseanne's surprise and Dan's consternation. When Crystal and Ed become engaged in Season 3, she reveals she is pregnant. Dan is initially unhappy with either development, further straining his already-difficult relationship with his father. Crystal gives birth to Ed Junior, better known as Little Ed; the following year, she gives birth to her daughter, Angela. Crystal made a few appearances in several revival-era episodes in 2018 and 2019. It is unmentioned if she is still married to Ed Conner. However, in The Conners, when Ed, Sr. dies, he was living alone in rather shabby circumstances.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.